Fig. 2
From: Mirabegron for overactive bladder in frail patients 80 years or over (HOKUTO study)
OABSS. Median ± IQR; #P < 0.01 (vs. week 0)
Fig. 2 | BMC Urology
From: Mirabegron for overactive bladder in frail patients 80 years or over (HOKUTO study)
OABSS. Median ± IQR; #P < 0.01 (vs. week 0)